Found: 43
Select item for more details and to access through your institution.
Urine S100 proteins as potential biomarkers of lupus nephritis activity.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1444-4
- By:
- Publication type:
- Article
Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy.
- Published in:
- Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-016-1212-x
- By:
- Publication type:
- Article
The 4<sup>th</sup> NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study.
- Published in:
- Pediatric Rheumatology, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00866-z
- By:
- Publication type:
- Article
Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019.
- Published in:
- Pediatric Rheumatology, 2020, v. 18, p. 1, doi. 10.1186/s12969-020-00444-7
- By:
- Publication type:
- Article
The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.
- Published in:
- Pediatric Rheumatology, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12969-020-0398-2
- By:
- Publication type:
- Article
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.
- Published in:
- Nature Genetics, 2014, v. 46, n. 10, p. 1140, doi. 10.1038/ng.3089
- By:
- Publication type:
- Article
Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Synergistic Signaling of TLR and IFNα/β Facilitates Escape of IL-18 Expression from Endotoxin Tolerance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lung Ultrasound in Children With Systemic Juvenile Idiopathic Arthritis–Associated Interstitial Lung Disease.
- Published in:
- Arthritis Care & Research, 2023, v. 75, n. 5, p. 983, doi. 10.1002/acr.24957
- By:
- Publication type:
- Article
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reply: To PMID 25988345.
- Published in:
- 2015
- By:
- Publication type:
- commentary
11-Month-Old Infant With Periodic Fevers, Recurrent Liver Dysfunction, and Perforin Gene Polymorphism.
- Published in:
- Arthritis Care & Research, 2015, v. 67, n. 8, p. 1173, doi. 10.1002/acr.22527
- By:
- Publication type:
- Article
IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome.
- Published in:
- Rheumatology, 2020, v. 59, n. 2, p. 361, doi. 10.1093/rheumatology/kez282
- By:
- Publication type:
- Article
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
- Published in:
- Rheumatology, 2017, v. 56, n. 9, p. 1542, doi. 10.1093/rheumatology/kex206
- By:
- Publication type:
- Article
Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 6, p. 649, doi. 10.1007/s40272-023-00593-8
- By:
- Publication type:
- Article
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00868-x
- By:
- Publication type:
- Article
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00865-0
- By:
- Publication type:
- Article
Proceedings from the 4<sup>th</sup> NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00863-2
- By:
- Publication type:
- Article
Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
- Published in:
- Pediatric Rheumatology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12969-021-00605-2
- By:
- Publication type:
- Article
MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti‐inflammatory functions in macrophages through two distinct mechanisms.
- Published in:
- Journal of Leukocyte Biology, 2018, v. 103, n. 1, p. 71, doi. 10.1002/JLB.2A0317-107R
- By:
- Publication type:
- Article
Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 7, p. 1334, doi. 10.1002/art.41640
- By:
- Publication type:
- Article
Platelet Glycoprotein Ib α‐Chain as a Putative Therapeutic Target for Juvenile Idiopathic Arthritis: A Mendelian Randomization Study.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 4, p. 693, doi. 10.1002/art.41561
- By:
- Publication type:
- Article
On the Alert for Cytokine Storm: Immunopathology in COVID‐19.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 7, p. 1059, doi. 10.1002/art.41285
- By:
- Publication type:
- Article
Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1943, doi. 10.1002/art.41073
- By:
- Publication type:
- Article
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 451, doi. 10.1002/art.40727
- By:
- Publication type:
- Article
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 9, p. 1508, doi. 10.1002/art.40509
- By:
- Publication type:
- Article
Brief Report: Novel UNC13D Intronic Variant Disrupting an NF‐κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 6, p. 963, doi. 10.1002/art.40438
- By:
- Publication type:
- Article
Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 7, p. 1480, doi. 10.1002/art.40099
- By:
- Publication type:
- Article
Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2300, doi. 10.1002/art.39694
- By:
- Publication type:
- Article
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 3, p. 566, doi. 10.1002/art.39332
- By:
- Publication type:
- Article
Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 1, p. 218, doi. 10.1002/art.39407
- By:
- Publication type:
- Article
Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, n. 12, p. 3486, doi. 10.1002/art.38793
- By:
- Publication type:
- Article
A6: Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S8, doi. 10.1002/art.38417
- By:
- Publication type:
- Article
A130: Is the CCR5-delta32 Mutation Protective Against Systemic-Onset Juvenile Idiopathic Arthritis?
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S171, doi. 10.1002/art.38551
- By:
- Publication type:
- Article
Correction: S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03347-0
- By:
- Publication type:
- Article
Genetic Defects in Cytolysis in Macrophage Activation Syndrome.
- Published in:
- Current Rheumatology Reports, 2014, v. 16, n. 9, p. 1, doi. 10.1007/s11926-014-0439-2
- By:
- Publication type:
- Article
Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease in the U.S. Real-World Settings.
- Published in:
- Rheumatology & Therapy, 2022, v. 9, n. 1, p. 265, doi. 10.1007/s40744-021-00402-z
- By:
- Publication type:
- Article
Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 10, p. 1566, doi. 10.1002/art.42938
- By:
- Publication type:
- Article
Recombinant Interleukin‐1 Receptor Antagonist Is an Effective First‐Line Treatment Strategy in New‐Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA‐DRB1 Background and IL1RN Variants.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 1, p. 119, doi. 10.1002/art.42656
- By:
- Publication type:
- Article
The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 10, p. 1714, doi. 10.1002/art.42636
- By:
- Publication type:
- Article
Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 7, p. 1271, doi. 10.1002/art.42099
- By:
- Publication type:
- Article